Regulation of HPV16 late gene expression during keratinocyte differentiation

角质形成细胞分化过程中 HPV16 晚期基因表达的调控

基本信息

  • 批准号:
    7230761
  • 负责人:
  • 金额:
    $ 16.95万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-05-01 至 2009-04-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Project Summary. The late genes of the papillomaviruses are transcribed throughout all stages of its life cycle. Paradoxically, late gene expression at the mRNA and protein level is restricted to late stages of keratinocyte differentiation when infectious virions are being produced. Although the molecular basis of this restriction is not known, a plausible contributory factor is the Negative Regulatory Element (NRE) found in the viral late gene's 3'UTR. The NREs of Bovine Papillomavirus 1 (BPV1) and human papillomavirus 16 (HVP16) inhibit late gene expression in reporter-based assays in both primary keratinocytes (the natural host cell) or in various cell lines. The BPV1 NRE inhibits by binding to the Ul snRNP splicing factor resulting in inhibition of polyA tail addition. Without a polyA tail, the viral late gene mRNA never matures and is presumably degraded by the nuclear exosome. In contrast to BPV1, the HPV16 NRE is far less understood and is more complicated because it consists of 4 weak, overlapping Ul snRNP binding sites linked to a downstream GU rich region of unknown function. This proposal has two overall goals, first to characterize the HPV16 NRE mechanistically and second to determine its importance to the viral life cycle within the natural environment of differentiating keratinocytes. It is important to note that the regulation of HPV16 genes at the RNA processing level is strikingly understudied when compared to the transcriptional level. The successful completion of this work will rigorously test the importance of the NRE to the viral life cycle and will lead to a mechanistic understanding of NRE function. Relevance. It is estimated that about 400,000 new cases of cervical carcinoma occur worldwide every year, and it is the second leading cause of cancer-related deaths among women after breast cancer. Human papillomavirus (HPV) DNA is found in over 90% of cervical cancers and is also prevalent in anogenital cancers. Epidemiologic and laboratory studies have shown a causative role for HPV and HPV 16 in these cancers. For this reason the molecular biology of the HPV 16 strain has been intensely studied. If this proposal successfully identifies new proteins that regulate viral late gene expression then new therapeutic approaches that disrupt the viral life cycle by disrupting these regulatory proteins can be pursued. Diagnostic tests, based on differential expression of these regulatory proteins, can also be developed.
描述(由申请人提供):项目摘要。乳头瘤病毒的晚期基因在其生命周期的所有阶段进行转录。矛盾的是,mRNA和蛋白质水平的晚期基因表达仅限于角质形成细胞分化的后期,此时感染性病毒粒子正在产生。尽管这种限制的分子基础尚不清楚,但一个可能的影响因素是在病毒晚期基因的 3'UTR 中发现的负调控元件 (NRE)。在基于报告基因的检测中,牛乳头瘤病毒 1 (BPV1) 和人乳头瘤病毒 16 (HVP16) 的 NRE 可抑制原代角质形成细胞(天然宿主细胞)或各种细胞系中的晚期基因表达。 BPV1 NRE通过结合U1 snRNP剪接因子来抑制,从而抑制polyA尾添加。如果没有多聚腺苷酸尾巴,病毒晚期基因 mRNA 永远不会成熟,并且可能会被核外泌体降解。与BPV1相比,HPV16 NRE知之甚少并且更加复杂,因为它由4个弱的、重叠的U1 snRNP结合位点组成,该结合位点与功能未知的下游富含GU的区域连接。该提案有两个总体目标,首先是从机制上表征 HPV16 NRE,其次是确定其在分化角质形成细胞的自然环境中对病毒生命周期的重要性。值得注意的是,与转录水平相比,HPV16 基因在 RNA 加工水平上的调控研究明显不足。这项工作的成功完成将严格检验 NRE 对病毒生命周期的重要性,并将导致对 NRE 功能的机械理解。关联。据估计,全球每年约有40万例新发宫颈癌病例,是继乳腺癌之后女性癌症相关死亡的第二大原因。人乳头瘤病毒 (HPV) DNA 存在于 90% 以上的宫颈癌中,在肛门生殖器癌症中也很常见。流行病学和实验室研究表明 HPV 和 HPV 16 在这些癌症中具有致病作用。因此,HPV 16 毒株的分子生物学得到了深入研究。如果该提议成功地识别出调节病毒晚期基因表达的新蛋白质,那么就可以寻求通过破坏这些调节蛋白来破坏病毒生命周期的新治疗方法。还可以开发基于这些调节蛋白的差异表达的诊断测试。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SAMUEL I GUNDERSON其他文献

SAMUEL I GUNDERSON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SAMUEL I GUNDERSON', 18)}}的其他基金

Regulation of HPV16 late gene expression during keratinocyte differentiation
角质形成细胞分化过程中 HPV16 晚期基因表达的调控
  • 批准号:
    7414527
  • 财政年份:
    2007
  • 资助金额:
    $ 16.95万
  • 项目类别:
REGULATION OF POLYADENYLATION--THE U1A/U1 SNRNP PARADIGM
多腺苷酸化的调控--U1A/U1 SNRNP 范式
  • 批准号:
    6490156
  • 财政年份:
    1999
  • 资助金额:
    $ 16.95万
  • 项目类别:
REGULATION OF POLYADENYLATION--THE U1A/U1 SNRNP PARADIGM
多腺苷酸化的调控--U1A/U1 SNRNP 范式
  • 批准号:
    6627219
  • 财政年份:
    1999
  • 资助金额:
    $ 16.95万
  • 项目类别:
Regulation of Polyadenylation: the U1A/U1snRNP Paradigm
多聚腺苷酸化的调控:U1A/U1snRNP 范式
  • 批准号:
    7061746
  • 财政年份:
    1999
  • 资助金额:
    $ 16.95万
  • 项目类别:
REGULATION OF POLYADENYLATION--THE U1A/U1 SNRNP PARADIGM
多腺苷酸化的调控--U1A/U1 SNRNP 范式
  • 批准号:
    6138648
  • 财政年份:
    1999
  • 资助金额:
    $ 16.95万
  • 项目类别:
REGULATION OF POLYADENYLATION--THE U1A/U1 SNRNP PARADIGM
多腺苷酸化的调控--U1A/U1 SNRNP 范式
  • 批准号:
    6343011
  • 财政年份:
    1999
  • 资助金额:
    $ 16.95万
  • 项目类别:
Regulation of Polyadenylation: the U1A/U1snRNP Paradigm
多聚腺苷酸化的调控:U1A/U1snRNP 范式
  • 批准号:
    6897517
  • 财政年份:
    1999
  • 资助金额:
    $ 16.95万
  • 项目类别:
REGULATION OF POLYADENYLATION--THE U1A/U1 SNRNP PARADIGM
多腺苷酸化的调控--U1A/U1 SNRNP 范式
  • 批准号:
    2758471
  • 财政年份:
    1999
  • 资助金额:
    $ 16.95万
  • 项目类别:
Regulation of Polyadenylation: the U1A/U1snRNP Paradigm
多聚腺苷酸化的调控:U1A/U1snRNP 范式
  • 批准号:
    7234304
  • 财政年份:
    1999
  • 资助金额:
    $ 16.95万
  • 项目类别:
Regulation of Polyadenylation: the U1A/U1snRNP Paradigm
多聚腺苷酸化的调控:U1A/U1snRNP 范式
  • 批准号:
    6825828
  • 财政年份:
    1999
  • 资助金额:
    $ 16.95万
  • 项目类别:

相似海外基金

Impact of alternative polyadenylation of 3'-untranslated regions in the PI3K/AKT cascade on microRNA
PI3K/AKT 级联中 3-非翻译区的替代多聚腺苷酸化对 microRNA 的影响
  • 批准号:
    573541-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 16.95万
  • 项目类别:
    University Undergraduate Student Research Awards
How do untranslated regions of cannabinoid receptor type 1 mRNA determine receptor subcellular localisation and function?
1 型大麻素受体 mRNA 的非翻译区如何决定受体亚细胞定位和功能?
  • 批准号:
    2744317
  • 财政年份:
    2022
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Studentship
MICA:Synthetic untranslated regions for direct delivery of therapeutic mRNAs
MICA:用于直接递送治疗性 mRNA 的合成非翻译区
  • 批准号:
    MR/V010948/1
  • 财政年份:
    2021
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Research Grant
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10019570
  • 财政年份:
    2019
  • 资助金额:
    $ 16.95万
  • 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10223370
  • 财政年份:
    2019
  • 资助金额:
    $ 16.95万
  • 项目类别:
Translational Control by 5'-untranslated regions
5-非翻译区域的翻译控制
  • 批准号:
    10455108
  • 财政年份:
    2019
  • 资助金额:
    $ 16.95万
  • 项目类别:
Synergistic microRNA-binding sites, and 3' untranslated regions: a dialogue of silence
协同的 microRNA 结合位点和 3 非翻译区:沉默的对话
  • 批准号:
    255762
  • 财政年份:
    2012
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Operating Grants
Analysis of long untranslated regions in Nipah virus genome
尼帕病毒基因组长非翻译区分析
  • 批准号:
    20790351
  • 财政年份:
    2008
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Search for mRNA elements involved in the compatibility between 5' untranslated regions and coding regions in chloroplast translation
寻找参与叶绿体翻译中 5 非翻译区和编码区之间兼容性的 mRNA 元件
  • 批准号:
    19370021
  • 财政年份:
    2007
  • 资助金额:
    $ 16.95万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Post-transcriptional Regulation of PPAR-g Expression by 5'-Untranslated Regions
5-非翻译区对 PPAR-g 表达的转录后调控
  • 批准号:
    7131841
  • 财政年份:
    2006
  • 资助金额:
    $ 16.95万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了